Suraksha Diagnostic Latest Share Price (SURAKSHA)
TODAY IN ONE LINE
SURAKSHA fell 2.2% on average volume, lagging Nifty's -0.4% move, supported by recent strong earnings.
With a market cap of ₹1,642.37 Cr., it trades at a P/E of 47.42. Track live valuations, technical indicators, and peers comparison below. Check delivery conviction and recent filings to build your view.
How good is this company?
Overall performance across 5 key dimensions.
Suraksha Diagnostic flags & news
Key strengths, potential risks, and recent updates.
Green Flags
- ●Quarterly OutperformanceLatest quarter Sales up 20.8% and Profit up 38.4%
- ●High Capital EfficiencyROCE of 17.0% indicating pricing power
- ●Healthy Operating MarginsOPM is structurally strong at 31.4%
- ●Promoter BuyingPromoters increased holdings by 0.10% QoQ
- ●Positive Free Cash FlowFCF has been positive for 3 consecutive years
- ●Zero Pledge RiskNo recent active promoter pledging found
Red Flags
- ●Earnings DeclineEPS (TTM) has contracted by 5.4% YoY
- ●Rising Receivables vs SalesReceivables grew 72.4% outpacing sales growth of 15.3%
Latest Suraksha Diagnostic News
What changed recently?
Recent events, corporate actions, and announcements.
Suraksha Diagnostic Ltd valuation: P/E, P/B and sector benchmarks.
Twelve years of multiples investors have paid for Suraksha Diagnostic Ltd, framed against the sector median so the premium or discount is obvious at a glance.
Suraksha Diagnostic Ltd trades at a P/E of 47.42× and P/B of 6.93×.
Market-priced ratios use the latest available quote; accounting metrics use the latest reported filing. Compare values with matched peers and the company's own history.
Valuation
Profitability
Growth
Financial Health
Suraksha Diagnostic Ltd technical analysis: indicators, pivots and CPR.
Latest RSI, MACD and moving-average signals plus the latest pivot and Central Pivot Range levels for Suraksha Diagnostic Ltd — derived from the latest tape, not yesterday's close.
Suraksha Diagnostic Ltd last traded at ₹316 with an intraday range of ₹313.1–₹324.2 — latest indicator, pivot and CPR signals below.
Pivot points
Standard pivot — most widely referenced.
Pivot levels · Classic
Last: ₹316.00| Level | Price (₹) | Distance | % Δ |
|---|---|---|---|
| R4 | 344.63 | +28.63 | +9.06% |
| R3 | 333.53 | +17.53 | +5.55% |
| R2 | 328.87 | +12.87 | +4.07% |
| R1 | 322.43 | +6.43 | +2.04% |
| PIVOT | 317.77 | 1.77 | 0.56% |
| CURRENT | 316.00 | — | — |
| S1 | 311.33 | -4.67 | -1.48% |
| S2 | 306.67 | -9.33 | -2.95% |
| S3 | 300.23 | -15.77 | -4.99% |
| S4 | 289.13 | -26.87 | -8.50% |
SURAKSHA is trading Below CPR, indicating Bearishness
CPR is Wider, suggesting unlikely for trending moves
Day's range: ₹314.2–₹324.2
Trading Below opening range, showing Bearishness
Suraksha Diagnostic Ltd financials: P&L, balance sheet, cash flow, ratios.
Reported annual and quarterly results for Suraksha Diagnostic Ltd — consolidated or standalone — with margins, YoY growth and key ratios inline.
Suraksha Diagnostic Ltd reports its full P&L, balance sheet, cash flow and ratios on this page — current market capitalisation of ₹1,642.37 Cr. and reported EPS of ₹6.87.
| Metric | Mar 2025 | Mar 2026 |
|---|---|---|
| Revenue from Operations | 252 | 310 ▲ 23.1% |
| Sales Growth YoY %Derived | — | 23.14% |
| Other Income | 4 | 3 ▼ 17.7% |
| Total Income | 256 | 314 ▲ 22.5% |
| 30 | 36 ▲ 23.6% | |
| Gross ProfitDerived | 223 | 274 ▲ 23.1% |
| Gross Margin %Derived | 88.29% | 88.25% |
| 141 | 179 ▲ 26.3% | |
| EBITDA (Operating Profit)Derived | 81 | 95 ▲ 17.4% |
| OPM %Derived | 32.23% | 30.73% |
| 44 | 54 ▲ 23.6% | |
| Profit Before Tax (PBT) | 41 | 45 ▲ 7.6% |
| 10 | 13 ▲ 26.2% | |
| Effective Tax %Derived | 25.18% | 29.52% |
| Total Profit for Period | 31 | 31 ▲ 1.4% |
| Less: Non-controlling Interests | -1 | -1 ▲ 7.3% |
| Net Profit (Owner's PAT)Derived | 32 | 32 ▲ 1.1% |
| Net Profit Margin %Derived | 12.62% | 10.37% |
| PAT Growth YoY %Derived | — | 1.14% |
| Earnings Per Share (EPS ₹) | 6.11 | 6.18 ▲ 1.1% |
| Diluted Shares Outstanding (Cr) | 5 | 5 ▲ 0.0% |
| Other Comprehensive Income (Net of Tax) | -0 | 1 ▲ 379.3% |
| Total Expenses (incl. D&A & Interest) | 215 | 269 ▲ 25.4% |
| Material Cost % of RevenueDerived | 11.71% | 11.75% |
| Employee Cost % of RevenueDerived | 17.01% | 17.16% |
| Other Cost % of RevenueDerived | 39.05% | 40.36% |
| Interest Coverage (x)Derived | 5.48x | 4.30x |
| Period | Mar 2025 | Mar 2026 | Trend |
|---|---|---|---|
| Revenue from Operations | 252 | 310 ▲ 23.1% | |
| Sales Growth YoY %Derived | — | 23.14% | |
| Other Income | 4 | 3 ▼ 17.7% | |
| Total Income | 256 | 314 ▲ 22.5% | |
30 | 36 ▲ 23.6% | ||
| Gross ProfitDerived | 223 | 274 ▲ 23.1% | |
| Gross Margin %Derived | 88.29% | 88.25% | |
141 | 179 ▲ 26.3% | ||
| EBITDA (Operating Profit)Derived | 81 | 95 ▲ 17.4% | |
| OPM %Derived | 32.23% | 30.73% | |
44 | 54 ▲ 23.6% | ||
| Profit Before Tax (PBT) | 41 | 45 ▲ 7.6% | |
10 | 13 ▲ 26.2% | ||
| Effective Tax %Derived | 25.18% | 29.52% | |
| Total Profit for Period | 31 | 31 ▲ 1.4% | |
| Less: Non-controlling Interests | -1 | -1 ▲ 7.3% | |
| Net Profit (Owner's PAT)Derived | 32 | 32 ▲ 1.1% | |
| Net Profit Margin %Derived | 12.62% | 10.37% | |
| PAT Growth YoY %Derived | — | 1.14% | |
| Earnings Per Share (EPS ₹) | 6.11 | 6.18 ▲ 1.1% | |
| Diluted Shares Outstanding (Cr) | 5 | 5 ▲ 0.0% | |
| Other Comprehensive Income (Net of Tax) | -0 | 1 ▲ 379.3% | |
| Total Expenses (incl. D&A & Interest) | 215 | 269 ▲ 25.4% | |
| Material Cost % of RevenueDerived | 11.71% | 11.75% | |
| Employee Cost % of RevenueDerived | 17.01% | 17.16% | |
| Other Cost % of RevenueDerived | 39.05% | 40.36% | |
| Interest Coverage (x)Derived | 5.48x | 4.30x |
Suraksha Diagnostic segment analysis : revenue and profit mix.
Disclosed business segments at Suraksha Diagnostic with their share of revenue and profit, switchable between consolidated and standalone reporting.
Suraksha Diagnostic discloses revenue and profit across multiple business segments — toggle between consolidated and standalone views to see the mix.
Segment-wise Financial Analysis
The Bull, Bear, and Flip case for Suraksha Diagnostic Ltd.
Our AI distills the core fundamental drivers supporting Suraksha Diagnostic Ltd, the risks that threaten it, and the quantitative conditions that could weaken the thesis.
Suraksha Diagnostic Ltd's investment case rests on 10 positive markers and 10 flagged concerns drawn from the latest reported filings.
What you're getting.
Operating margin 17.53% TTM exceeds peer KRSNAA at 15.7%, signaling superior operational efficiency.
ROCE 17.80% and ROE 13.84% outpace KRSNAA benchmarks, demonstrating stronger capital deployment.
Debt-to-equity ratio 0.54x indicates moderate leverage with substantial financial flexibility.
Operating cash flow ₹80.23 Cr supports network expansion and liquidity with strong cash conversion.
Promoter holding 49.10% signals strong management alignment with shareholder interests.
Key Risks.
Latest quarterly EPS declined 15.0% YoY despite revenue growth momentum, signaling earnings deceleration.
TTM EPS declined 5.4% YoY indicating sustained earnings pressure amid 31.2% TTM revenue growth.
P/E ratio 43.37x significantly elevated versus peer median ~20x, reflecting stretched valuation multiples.
Dividend yield 0.19% offers minimal income for yield-focused investors seeking regular returns.
FII holdings eased from 15.39% to 13.46%, signaling foreign investor caution on valuation concerns.
Flip Conditions.
Valuation risk. a P/E above 62 would leave less room for earnings disappointment.
Reassess if quarterly profit growth turns negative for two consecutive quarters. The bull case relies on compounding earnings.
Watch interest coverage if debt-to-equity climbs above 1.03. Balance sheet risk re-prices growth multiples fast.
Return-quality risk. ROE below 9% would indicate weaker capital compounding.
Suraksha Diagnostic Ltd peer comparison — same-sector benchmarks.
Same-sector listed peers ranked on P/E, market cap, dividend yield and growth — Suraksha Diagnostic Ltd is highlighted for quick read-across.
Quick Compare
Peer Comparison
| Company Name |
|---|
Suraksha Diagnostic Ltd chart patterns: breakouts, tops and bottoms.
Auto-detected classical chart patterns for Suraksha Diagnostic Ltd — Double Top/Bottom, Head & Shoulders, Triple Bottom and more — with break levels, targets and quality scores across Intraday, Daily and Weekly timeframes.
Suraksha Diagnostic Ltd delivery volume — last 20 sessions of conviction.
Daily traded volume and delivery percentage for Suraksha Diagnostic Ltd over 20 sessions — the gap between intraday flipping and genuine accumulation.
Latest session delivery in Suraksha Diagnostic Ltd stood at 46.0% of traded volume, against a 20-day average of 53.3%.
Suraksha Diagnostic announcements: results, concalls, ratings, M&A.
Filings Suraksha Diagnostic sent to the exchanges, sequenced as they hit the tape — concall transcripts, results, credit ratings and presentations.
Suraksha Diagnostic files concall transcripts, results, credit ratings and corporate-action notices on the NSE and BSE exchange portals — latest 74 documents below.
Analysts/Institutional Investor Meet/Con. Call Updates
Suraksha Diagnostic Limited has informed the Exchange about Transcript
Analysts/Institutional Investor Meet/Con. Call Updates
Suraksha Diagnostic Limited has informed the Exchange about Transcript
Analysts/Institutional Investor Meet/Con. Call Updates
Suraksha Diagnostic Limited has informed the Exchange about Link of Recording
Analysts/Institutional Investor Meet/Con. Call Updates
Suraksha Diagnostic Limited has informed the Exchange about Link of Recording
Copy of Newspaper Publication
Suraksha Diagnostic Limited has informed the Exchange about Copy of Newspaper Publication
Investor decks & rating reports.
Suraksha Diagnostic dividend history, splits and bonus issues.
Every dividend, stock split and bonus issue Suraksha Diagnostic has declared, sequenced by announce and record date.
Suraksha Diagnostic corporate-action history below covers all declared dividends, stock splits and bonus issues recorded with NSE and BSE.
Suraksha Diagnostic insider trading: promoter and management activity.
Promoter, director and designated-employee transactions in Suraksha Diagnostic as reported to SEBI — buying and selling signals from the people who know the business best.
Suraksha Diagnostic insider activity below tracks 1 reported promoter, director and designated-employee transactions under SEBI Regulation 7(2).
| Insider | Category | Txn Date | Action | Quantity | Value (₹) | Price |
|---|---|---|---|---|---|---|
| Dr. Somnath Chatterjee | Insider | 13 Jun 2025 | buy | +7.6 K | ₹24.85 L | ₹327.41 |
About Suraksha Diagnostic Ltd: business, sector, key facts.
What Suraksha Diagnostic Ltd does, where it operates, the people running it, and the numbers that describe the entity behind the ticker.
Suraksha Diagnostic Ltd operates in the Healthcare Service Provider industry under the Healthcare sector, listed as NSE: SURAKSHA, BSE: 544293.
Suraksha Diagnostic Limited is a prominent player in India's diagnostic healthcare industry, operating a network of diagnostic centers throughout the country. The company's core business revolves around providing a comprehensive suite of diagnostic testing services to patients and healthcare professionals. This wide-ranging portfolio contributes to their significant market presence and caters to a diverse client base.
A significant portion of Suraksha's revenue stems from its pathology testing services. This encompasses a broad spectrum of laboratory analyses, allowing for the detection and diagnosis of various medical conditions. The precise nature and extent of these pathology tests are not detailed in the provided information, but the breadth of services offered is clearly a key component of their business model.
Further enhancing its diagnostic capabilities, Suraksha offers a comprehensive range of radiology services. This includes advanced imaging techniques such as Magnetic Resonance Imaging (MRI), Computed Tomography (CT) scans, and Dual-Energy X-ray Absorptiometry (DEXA) scans. These technologies provide detailed internal images of the body, assisting in the diagnosis and monitoring of a variety of health issues. Their radiology offerings also extend to interventional ultrasonography, CT-guided biopsies, and standard X-ray imaging, illustrating a dedication to comprehensive and technologically advanced diagnostic practices.
In addition to its core diagnostic testing services, Suraksha also provides medical consultation services. While the specifics of these services are not detailed, the inclusion of this element suggests an integrated approach to patient care, potentially offering a more holistic and convenient experience by combining diagnostic testing with preliminary medical advice. This could involve consultations with physicians or other healthcare professionals associated with the company.
Established in 1992 and headquartered in Kolkata, India, Suraksha Diagnostic Limited has a long history of serving the healthcare needs of the Indian population. Its continued growth and expansion within the diagnostic services sector demonstrates its success in meeting the demand for accurate and timely diagnostic information.
Related
Peers, sector trends, screeners and strategy playbooks contextual to this stock.
- Health X Platform (HEALTHX) Share PricePeer
- Krsnaa Diagnostics (KRSNAA) Share PricePeer
- Dr Lal Path Labs (LALPATHLAB) Share PricePeer
- Metropolis Healthcare (METROPOLIS) Share PricePeer
- Thyrocare Technologies (THYROCARE) Share PricePeer
- Other overvalued NSE stocksScreener
- Top Gainers TodayScreener
- EMA Crossover ScreenerScreener
- Stock Quality ScorecardScreener
- Technical DashboardScreener
- Results CalendarScreener
- FII Buying ActivityScreener
- All Technical ScreenersScreener
- All Trading StrategiesStrategy
Questions investors ask about Suraksha Diagnostic Ltd (SURAKSHA).
Quick answers grounded in this page's data — price action, fundamentals, ratios and ownership.
01What is the current share price of Suraksha Diagnostic Ltd (SURAKSHA)?
The current share price of Suraksha Diagnostic Ltd (SURAKSHA) is ₹316.00. Today, the stock has declined by ₹7.10 (2.2%), trading in a range of ₹313.10 to ₹324.20. The stock opened at ₹323.10 with a trading volume of 57,621 shares.
02Is Suraksha Diagnostic Ltd stock a good investment for long-term?
Suraksha Diagnostic Ltd can be considered for long-term investment based on several factors. The company has a market capitalization of ₹1,642.37 Cr., P/E ratio of 47.42, ROE of 14.1%, and ROCE of 17%. The dividend yield stands at 0.16%. However, investment decisions should be based on your financial goals, risk appetite, and thorough research. It's recommended to consult with a SEBI-registered financial advisor before making investment decisions.
03What is the 52-week high and low price of Suraksha Diagnostic Ltd stock?
The 52-week high price of Suraksha Diagnostic Ltd (SURAKSHA) is ₹333.00, while the 52-week low is ₹224.10. Currently trading at ₹316.00, the stock is 41.01% above its 52-week low and 5.11% below its 52-week high. These levels help investors understand the stock's price volatility and trading range over the past year.
04Should I buy Suraksha Diagnostic Ltd stock at the current price?
Whether to buy Suraksha Diagnostic Ltd stock at ₹316.00 depends on multiple factors. The stock is currently trading with a P/E ratio of 47.42 and P/B ratio of 6.93. Today's performance shows a loss of 2.2%. Consider analyzing the company's fundamentals, technical indicators, industry trends, and your investment horizon. Compare these metrics with industry peers and consult a financial advisor for personalized advice.
05What is the dividend yield of Suraksha Diagnostic Ltd and when is the next dividend?
Suraksha Diagnostic Ltd offers a dividend yield of 0.16%, which means for every ₹100 invested at the current price of ₹316.00, you can expect to receive approximately ₹0.16 annually as dividends. The face value of the stock is ₹2.00. For information about the next dividend announcement and ex-dividend date, please check the company's official announcements or visit the BSE/NSE websites.
06What are the key financial ratios and metrics of Suraksha Diagnostic Ltd?
Suraksha Diagnostic Ltd's key financial metrics include: P/E Ratio: 47.42, P/B Ratio: 6.93, ROE: 14.1%, ROCE: 17%, Dividend Yield: 0.16%, EPS: ₹6.87, Book Value: ₹47.00, and Debt-to-Equity: 0.53. The company's market cap stands at ₹1,642.37 Cr.. These metrics help evaluate the company's valuation, profitability, and financial health.
07How is Suraksha Diagnostic Ltd stock performing today in the market?
Suraksha Diagnostic Ltd stock opened at ₹323.10 and is currently trading at ₹316.00, showing a decline of ₹7.10 (2.2%). The intraday high is ₹324.20 and low is ₹313.10. The trading volume stands at 57,621 shares, indicating moderate market participation today.
08What is the P/E ratio of Suraksha Diagnostic Ltd and what does it indicate?
Suraksha Diagnostic Ltd has a Price-to-Earnings (P/E) ratio of 47.42, which means investors are willing to pay 47.42 for every ₹1 of earnings. With an EPS of ₹6.87, this P/E ratio suggests the stock may be trading at a premium, possibly due to high growth expectations. Compare this with industry peers and historical P/E ratios for better context.
The data, ratios and commentary about Suraksha Diagnostic Ltd (SURAKSHA) on this page are published for educational and informational purposes only and are not investment, legal or tax advice. StockeZee is not a SEBI-registered investment adviser, research analyst or portfolio manager, and no content here should be construed as a recommendation to buy, hold or sell any security. Live and historical market data may be delayed, revised by the exchanges, or contain errors; figures sourced from third-party feeds and corporate disclosures may not always be current. Past performance is not indicative of future results, and equity investments carry the risk of capital loss. Before acting on anything you read here, please consult a SEBI-registered financial advisor and read all scheme-related documents carefully.